VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance is a research paper published in Science (2020). On theSindex it has a DataRank of 0. It has been cited 290 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Office of the Director
Grant: R01AR070760
NIH Office of the Director
Grant: R01CA214062
NIH Office of the Director
Grant: RR180061
NIH Office of the Director
Grant: R01HL56067
NIH Office of the Director
Grant: R01 HL 11879
NIH Office of the Director
Grant: R37 AI34495
NHLBI NIH HHS
Grant: R01 HL056067
NHLBI NIH HHS
Grant: R01 HL147324
NHLBI NIH HHS
Grant: R01 HL118979
NIH HHS
Grant: S10 OD025235
NCI NIH HHS
Grant: P01 CA065493
NCI NIH HHS
Grant: R21 CA227996
NIAID NIH HHS
Grant: R37 AI034495
NCI NIH HHS
Grant: P30 CA023108
NCI NIH HHS
Grant: P01 CA142106
NIAID NIH HHS
Grant: R01 AI038903
NIAID NIH HHS
Grant: R01 AI148430
NCI NIH HHS
Grant: T32 CA009138
National Institutes of Health
Grant: 3P30CA023108-41S8
Cancer Center Support Grant
National Institutes of Health
Grant: 1R21CA227996-01A1
Computational Identification of new candidate drugs for lung cancer treatment
National Institutes of Health
Grant: 5R01CA180061-02
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
National Institutes of Health
Grant: 5R01AR070760-02
Negative regulation of Lupus by the VISTA Pathway
National Institutes of Health
Grant: 5R01HL056067-21
T-Cell Targeting for GVHD
National Institutes of Health
Grant: 5R01CA214062-02
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
National Institutes of Health
Grant: 4R37AI034495-30
In Vivo Prevention of Murine GVHD
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
Additional file 1 of IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy